Premature ovarian insufficiency tied to pelvic radiotherapy, alkylating agent exposure

Women who had childhood cancer may have an increased risk for premature ovarian insufficiency after treatment with pelvic radiotherapy and alkylating agents, study data show.

Read more: http://www.healio.com/endocrinology/reproduction-androgen-disorders/news/in-the-journals/%7Be3d8cc36-542e-4c3b-89ac-c034169eda0e%7D/premature-ovarian-insufficiency-tied-to-pelvic-radiotherapy-alkylating-agent-exposure